<ul><li>The CRISPR pioneers in 2012 missed crucial technical details in their patent application, costing them valuable European patent rights.</li><li>Their first patent application did not include the critical PAM sequence, making it impossible for other scientists to replicate their invention.</li><li>By the time they filed a second patent with the PAM sequence, their own Science paper had already disclosed the invention, rendering the patent invalid.</li><li>Publishing a scientific paper without securing patent rights can lead to the loss of patentable innovation.</li></ul>

Lost Your Patent Rights? These Nobel Winners Did Too

Discover more